In the present study, we have tested the hypothesis that Romidepsin promotes the acetylation of non-histone proteins that regulate transcription leading to a downregulation of VCAM-1 expression by EC, which is of critical functional importance to atherosclerosis. The gene discussed is VCAM1; the disease is atherosclerosis.